TY  -  JOUR
AU  -  Zavaleta-Monestel, Esteban
AU  -  Arguedas-Chacón, Sebastián
AU  -  Mora-Jiménez, Jeaustin
AU  -  Herrera Jiménez, Luis
AU  -  Castro Gamboa, José
AU  -  Moya Rohrmoser, Montserrat
AU  -  Zovi, Andrea
T1  -  Clinical pharmacist activities in the surgery department:
a retrospective descriptive analysis of pharmacotherapy optimization, patient education, and surgical antibiotic prophylaxis in a tertiary hospital
PY  -  2026
Y1  -  2026-07-01
DO  -  10.1721/4789.48150
JO  -  Giornale Italiano di Farmacia Clinica
JA  -  GIFAC
VL  -  40
IS  -  3
SP  -  136
EP  -  145
PB  -  Il Pensiero Scientifico Editore
SN  -  1120-3749
Y2  -  2026/11/13
UR  -  http://dx.doi.org/10.1721/4789.48150
N2  -  Summary. Introduction. Clinical pharmacists contribute to pharmacotherapy optimization and patient safety in surgical settings; however, data describing their activities in this context remain limited, particularly in Latin America. The analysis aims to describe the clinical interventions and patient education activities performed by the clinical pharmacist for surgical patients, while identifying the medications involved in drug-related problems (DRPs) and assessing adherence to institutional antibiotic prophylaxis guidelines. Material and methods. This retrospective descriptive analysis of de-identified institutional registry data described the activities of a clinical pharmacist in the surgical service of a Costa Rican hospital, between January and September 2025. Data were obtained from three institutional registries: pharmaceutical interventions, surgical patient education, and surgical antibiotic prophylaxis monitoring. The analysis included 92 pharmaceutical intervention records involving 103 medication-related entries, 394 patients receiving 2035 recorded education actions across multiple counseling topics, and 353 surgical procedures evaluated for adherence to institutional antibiotic prophylaxis guidelines. Drug-related problems were classified using the Pharmaceutical Care Network Europe (PCNE) v9.1 framework, and medications were categorized using the Anatomical Therapeutic Chemical (ATC) classification (level 2). Results. Among pharmaceutical interventions, the most frequent categories were dose adjustment or selection (37%), pharmacological education (17%), medication selection (13%), and under- or over-treated conditions (13%). Acceptance of pharmacist recommendations varied by professional group, reaching 100% among nursing staff, 81% among anesthesiologists, 54% among surgeons, and 40% among attending physicians. Antibiotics represented 72.8% of medications involved in interventions. Among 364 recorded prophylaxis deviation events, the most frequent categories were antibiotic use without indication (39.0%), inappropriate antimicrobial selection (36.0%), and underdosing (25.0%). Conclusions. These findings describe recorded clinical pharmacist activities in perioperative care and identify areas for quality improvement, particularly interprofessional communication and adherence to institutional surgical antibiotic prophylaxis protocols. Because clinical outcomes were not evaluated, the results should be interpreted from a descriptive perspective.
ER  -   
